SELECT Data: Enrollment Statistics
SELECT, the largest-ever prostate cancer prevention trial, is testing selenium and vitamin E (alone or in combination) to see if these supplements may prevent prostate cancer. SELECT began enrolling patients on August 21, 2001, and hopes to enroll 32,400 men over a five-year period.
In the first two years of recruitment (August 21, 2001, to August 20, 2003):
- 24,639 men have been enrolled, or 76 percent of the total enrollment goal.
- Of these, 3,526 are African Americans, comprising 14 percent of the enrolled total
The median age of SELECT participants is 62. The oldest participant enrolled at the age of 93.
A diverse group of men have joined SELECT. As of August 20, 2003:
- 79 percent are white.
- 13 percent are African-American.
- 5 percent are Hispanic (non-African-American).
- 1 percent are Hispanic (African-American).
- 1 percent are Asian/Pacific Islander.
Incidence of prostate cancer
- In men, prostate cancer is the most common cancer after skin cancer.
- Prostate cancer is the second highest cause of cancer death in men in the U.S.
- African-American men in the U.S. have the highest prostate cancer rates in the world.
To get more information...
...or to locate a participating center, call 1-800-4-CANCER in the United States and Puerto Rico or 1-888-939-3333 in Canada. For a collection of material about SELECT, visit Digest Page: The SELECT Prostate Cancer Prevention Trial.
|SELECT Enrollment by Canadian Province as of Aug. 2003|
|Canadian Province||Number||Canadian Province||Number|